project |
|
|---|---|
|
Name/scientific name |
TAFAMIDIS MEGLUMINE
|
|
Self-financed or subsidized by the Hospital Authority |
Hospital Authority Drug Formulary
|
|
Indications |
familial amyloidosis cardiomyopathy, familial amyloidosis polyneuropathy
|
|
body system |
|
|
type |
|
Tafamidis Meglumine (Tafamidis Meglumine) is a prescription medicine used to treat people with progressive familial amyloidosis (ATTR). ATTR is a rare genetic disorder that causes protein deposits in the body, impairing organ function. Tafamidis Meglumine helps slow disease progression and improve patients' quality of life by preventing protein deposition in the body. Patients should take the medication as recommended by their doctor, usually once daily. During the period of taking, some side effects may occur, such as headache, diarrhea, fatigue, etc. If serious adverse reactions occur, you should seek medical attention immediately. In Hong Kong, Tafamidis Meglumine requires a doctor's prescription to purchase, and patients should undergo regular medical monitoring during use to ensure efficacy and safety.
How to use: TAFAMIDIS MEGLUMINE is an oral medication that should be taken at the same time every day. Can be taken with food or on an empty stomach, depending on individual circumstances. During the period of taking, you should avoid eating foods rich in fat to ensure the absorption of the drug.
Dosage Guidelines: For adults, the recommended starting dose is 20 mg daily divided into 10 mg doses. Your physician may adjust the dose based on individual tolerance and severity of illness, but the maximum dose should not exceed 80 mg daily. For children, the dosage should be determined based on weight and age. The appropriate dosage should be determined under the guidance of a physician, and the dosage should be adjusted regularly.
Remember to strictly follow your doctor's advice when using the medication and do not adjust the dosage or stop using the medication on your own. If you have any questions or adverse reactions, you should consult a medical professional immediately.
TAFAMIDIS MEGLUMINE is a drug used to treat heart disease associated with familial thalassemia. Its side effects may include dizziness, diarrhea, abnormal liver function and nausea. Some patients have also reported adverse reactions such as rash and muscle pain. If you experience serious side effects, such as difficulty breathing, rapid heartbeat, or allergic reaction, seek medical advice immediately. Before seeing a doctor, remember to discuss your medical history and use of other medications with your doctor to avoid adverse effects.
The drug Tafamidis Meglumine is used to treat certain types of hereditary amyloidosis, such as familial Mediterranean fever. However, this drug has some contraindications. First, patients with an allergic reaction, especially those who are allergic to Tafamidis Meglumine or any of its ingredients, should avoid using this drug. Secondly, the use of this drug should also be prohibited for pregnant or breastfeeding women, and children under the age of 18. In addition, for patients with severe renal dysfunction, Tafamidis Meglumine should be used with caution, preferably under the guidance of a physician. While taking this medicine, you should try to avoid drinking alcohol, as alcohol may affect the effectiveness of the medicine. In general, patients should carefully evaluate their medical history and health status before using Tafamidis Meglumine to ensure that they meet the conditions for use, and use it under the supervision of a physician to ensure safe and effective treatment of the disease.
Tafamidis Meglumine
Precautions for use: Use this medication as directed by your doctor or pharmacist. Do not exceed recommended dosage. If you have any discomfort or concerns, please seek professional medical advice immediately.
We are the first medical service company in Hong Kong that can complete appointment, communication and payment all through mobile phones. You can easily make an appointment for nursing services through your mobile phone in as little as 3 minutes. The whole process can be done by mobile phone. There is no need to make phone calls and wait for an agency to respond to the selection of medical staff.
traditional care agency
careEASY
Registered Nurse (12 hours)
$3300
$2900(-12%)
Enrolled Nurse (12 hours)
$2900
$2600(-10%)
Health Assistant (12 hours)
$1600
$1200 (-25%)
Transparent fees
Free choice of medical care candidates
Communicate directly with healthcare providers
Single service charge
Credit Card/Apple Pay
Using Tafamidis Meglumine (a drug used to treat familial thalassemia) during pregnancy may cause risks to the fetus. Use of this medication before or during pregnancy should be done with caution and under the supervision of a doctor. If you are pregnant or plan to become pregnant, tell your doctor right away. Your doctor may need to evaluate the risks and benefits of the medication and develop the most appropriate treatment plan for your specific situation.
During pregnancy, follow your doctor's advice and tell your doctor immediately if you have any discomfort or concerns. Be careful to avoid stopping the medication or changing the dose on your own, as this may cause harm to the mother and fetus. Make sure to get regular check-ups and monitoring during pregnancy to ensure the health of mother and baby.
In summary, the use of Tafamidis Meglumine during pregnancy requires caution and respect for the professional advice of your doctor to ensure safe and effective treatment of the disease.
No longer restricted by traditional medical care intermediaries, doctors, nurses and customers also have the right to choose! You can also make remote reservations via mobile phone when you are away from home, no need to call to make reservations for family members!
©2024 All Rights Reserved. Created with LOVE and coffee in 🇭🇰